(Q56901322)

English

Phase I trial of an enhanced prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer

article

In more languages
default for all languages
No label defined

No description defined

Statements

Phase I trial of an enhanced prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer (English)
0 references
0 references
0 references
Marc R Theoret
0 references
Philip M Arlen
0 references
Mary Pazdur
0 references
William L Dahut
0 references
June 2007
0 references
5
0 references
5
0 references
347-50
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit